- Body image distress (BID) appears to be a significant factor in elevated symptoms of anxiety and depression among patients with polycystic ovary syndrome (PCOS).
Why this matters
- Therapeutic interventions targeted at improving body image may be beneficial.
- On Multidimensional Body-Self Relations-Appearance subscale (MBSRQ-AS) for BID, patients with PCOS had reduced scores for Appearance Evaluation (2.6 vs 3.4; P<.001 and body areas satisfaction vs p control individuals.>
- Higher scores were observed for Appearance Orientation (3.8 vs 3.6; P=.002), Overweight Preoccupation (3.4 vs 2.8; P<.001 and self-classified weight vs p=".013).</li">
- Patients with PCOS also had larger differences compared with control individuals for Stunkard Figure Rating Scale Score 1 (P=.020) and Score 2 (P=.011); for both, the values were indicative of BID.
- Patients with PCOS had higher prevalence of depressive symptoms (28% vs 19.2%; P<.001 and anxiety symptoms vs p on the hospital depression scale in multivariate analysis.>
- Most MBSRQ-AS subscale scores showed a statistically significant correlation with depression, anxiety, and QoL scores
- 189 reproductive-aged women with PCOS and 225 control subjects were analyzed for BID, depression, and anxiety.
- Funding: NIH.
- Observational study design could have residual confounders.